{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:34:37Z","timestamp":1788957277344,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-024-09583-5","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:06:04Z","timestamp":1736852764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Protective role of ABCC drug subfamily resistance transporters (ABCC1-7) in intestinal inflammation"],"prefix":"10.1007","volume":"73","author":[{"given":"Gabriela","family":"Fonseca-Camarillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Furuzawa-Carballeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Miguel-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Barreto-Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braulio","family":"Mart\u00ednez-Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus K.","family":"Yamamoto-Furusho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"9583_CR1","doi-asserted-by":"publisher","unstructured":"Baars MJD, Floor E, Sinha N, Ter Linde JJM, van Dam S, Amini M, Nijman IJ, Ten Hove JR, Drylewicz J, Offerhaus GJA, Lacl\u00e9 MM, Oldenburg B, Vercoulen Y. 2024 Multiplex spatial omics reveals changes in immune-epithelial crosstalk during inflammation and dysplasia development in chronic IBD patients. iScience. 27 8 110550. https:\/\/doi.org\/10.1016\/j.isci.2024.110550","DOI":"10.1016\/j.isci.2024.110550"},{"issue":"9","key":"9583_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1097\/MIB.0000000000000477","volume":"21","author":"G Fonseca-Camarillo","year":"2015","unstructured":"Fonseca-Camarillo G, Yamamoto-Furusho JK. Immunoregulatory pathways involved in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(9):2188\u201393. https:\/\/doi.org\/10.1097\/MIB.0000000000000477.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"9583_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","volume":"13","author":"P Hindryckx","year":"2016","unstructured":"Hindryckx P, Jairath V, D\u2019Haens G. Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016;13(11):654\u201364. https:\/\/doi.org\/10.1038\/nrgastro.2016.116.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9583_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"BR Sartor","year":"2006","unstructured":"Sartor BR. Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390\u2013407.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"9583_CR5","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3748\/wjg.v20.i12.3255","volume":"20","author":"XR Xu","year":"2014","unstructured":"Xu XR, Liu CQ, Feng BS, et al. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014;20:3255\u201364.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"9583_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/egh.11.23","volume":"5","author":"GC Actis","year":"2011","unstructured":"Actis GC, Rosina F, Mackay IR. Inflammatory bowel disease: beyond the boundaries of the bowel. Expert Rev Gastroenterol Hepatol. 2011;5(3):401\u201310. https:\/\/doi.org\/10.1586\/egh.11.23.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"9583_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nri1784","volume":"6","author":"DH Adams","year":"2006","unstructured":"Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol. 2006;6(3):244\u201351. https:\/\/doi.org\/10.1038\/nri1784.","journal-title":"Nat Rev Immunol"},{"key":"9583_CR8","doi-asserted-by":"publisher","first-page":"5536563","DOI":"10.1155\/2021\/5536563","volume":"2021","author":"MA Villeda-Ram\u00edrez","year":"2021","unstructured":"Villeda-Ram\u00edrez MA, Meza-Guillen D, Barreto-Z\u00fa\u00f1iga R, Yamamoto-Furusho JK. ABCC7\/CFTR expression is associated with the clinical course of ulcerative colitis patients. Gastroenterology research and practice. 2021;2021:5536563. https:\/\/doi.org\/10.1155\/2021\/5536563.","journal-title":"Gastroenterology research and practice"},{"issue":"2","key":"9583_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12263-007-0051-4","volume":"2","author":"YE Dommels","year":"2007","unstructured":"Dommels YE, Butts CA, Zhu S, Davy M, Martell S, Hedderley D, Barnett MP, McNabb WC, Roy NC. Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-\/-) mice. Genes Nutr. 2007;2(2):209\u201323. https:\/\/doi.org\/10.1007\/s12263-007-0051-4.","journal-title":"Genes Nutr"},{"issue":"8","key":"9583_CR10","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1007\/s10620-013-2636-7","volume":"58","author":"N Verma","year":"2013","unstructured":"Verma N, Ahuja V, Paul J. Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators. Dig Dis Sci. 2013;58(8):2282\u201392. https:\/\/doi.org\/10.1007\/s10620-013-2636-7.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"9583_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ibd.21016","volume":"16","author":"JK Yamamoto-Furusho","year":"2010","unstructured":"Yamamoto-Furusho JK, Villeda-Ram\u00edrez MA, Fonseca-Camarillo G, S\u00e1nchez-Mu\u00f1oz F, Dominguez-Lopez A, Barreto-Zu\u00f1iga R, Uribe M. High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis. Inflamm Bowel Dis. 2010;16(4):541\u20132. https:\/\/doi.org\/10.1002\/ibd.21016.","journal-title":"Inflamm Bowel Dis"},{"issue":"51","key":"9583_CR12","doi-asserted-by":"publisher","first-page":"35630","DOI":"10.1074\/jbc.M804374200","volume":"283","author":"H Blokzijl","year":"2008","unstructured":"Blokzijl H, van Steenpaal A, Vander Borght S, Bok LI, Libbrecht L, Tamminga M, Geuken M, Roskams TA, Dijkstra G, Moshage H, Jansen PL, Faber KN. Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease. J Biol Chem. 2008;283(51):35630\u20137. https:\/\/doi.org\/10.1074\/jbc.M804374200.","journal-title":"J Biol Chem"},{"key":"9583_CR13","doi-asserted-by":"publisher","unstructured":"Franco, R., Zavala-Flores, L. (2012). ABCC transporters. In: Schwab, M. (eds) Encyclopedia of cancer. Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/978-3-642-27841-9_7076-2","DOI":"10.1007\/978-3-642-27841-9_7076-2"},{"issue":"3","key":"9583_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/03602531003654915","volume":"42","author":"X Gu","year":"2010","unstructured":"Gu X, Manautou JE. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev. 2010;42(3):482\u2013538. https:\/\/doi.org\/10.3109\/03602531003654915.","journal-title":"Drug Metab Rev"},{"issue":"8","key":"9583_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bcp.2011.12.042","volume":"83","author":"Y Fukuda","year":"2012","unstructured":"Fukuda Y, Schuetz JD. ABC transporters and their role in nucleoside and nucleotide drug resistance. Biochem Pharmacol. 2012;83(8):1073\u201383. https:\/\/doi.org\/10.1016\/j.bcp.2011.12.042.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"9583_CR16","doi-asserted-by":"publisher","first-page":"e00005","DOI":"10.1002\/prp2.5","volume":"1","author":"S Takenaka","year":"2013","unstructured":"Takenaka S, Itoh T, Fujiwara R. Expression pattern of human ATP-binding cassette transporters in skin. Pharmacol Res Perspect. 2013;1(1):e00005. https:\/\/doi.org\/10.1002\/prp2.5.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"9583_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.109.002014","volume":"62","author":"CD Klaassen","year":"2010","unstructured":"Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010;62(1):1\u201396. https:\/\/doi.org\/10.1124\/pr.109.002014.","journal-title":"Pharmacol Rev"},{"issue":"18","key":"9583_CR18","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","volume":"278","author":"ZS Chen","year":"2011","unstructured":"Chen ZS, Tiwari AK. Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J. 2011;278(18):3226\u201345. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08235.x.","journal-title":"FEBS J"},{"issue":"4","key":"9583_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","volume":"17","author":"YK Zhang","year":"2015","unstructured":"Zhang YK, Wang YJ, Gupta P, Chen ZS. Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J. 2015;17(4):802\u201312. https:\/\/doi.org\/10.1208\/s12248-015-9757-1.","journal-title":"AAPS J"},{"issue":"1","key":"9583_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/mi.2017.31","volume":"11","author":"GT Ho","year":"2018","unstructured":"Ho GT, Aird RE, Liu B, Boyapati RK, Kennedy NA, Dorward DA, Noble CL, Shimizu T, Carter RN, Chew E, Morton NM, Rossi AG, Sartor RB, Iredale JP, Satsangi J. MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunol. 2018;11(1):120\u201330. https:\/\/doi.org\/10.1038\/mi.2017.31.","journal-title":"Mucosal Immunol"},{"key":"9583_CR21","doi-asserted-by":"publisher","unstructured":"Yamamoto-Furusho, J. K., Bozada-Guti\u00e9rrez, K. E., S\u00e1nchez-Rodr\u00edguez, A., Bojalil-Romano, F., Barreto-Zu\u00f1iga, R., & Mart\u00ednez-Benitez, B. (2019). Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: a prospective cohort study. Validaci\u00f3n de un nuevo \u00edndice integral de enfermedad para evaluar el grado de actividad en pacientes mexicanos con colitis ulcerosa: un estudio de cohorte prospectivo. Revista de gastroenterologia de Mexico (English), 84(3), 317\u2013325. https:\/\/doi.org\/10.1016\/j.rgmx.2018.07.006","DOI":"10.1016\/j.rgmx.2018.07.006"},{"issue":"1","key":"9583_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcmgh.2017.03.010","volume":"4","author":"K Oh-Oka","year":"2017","unstructured":"Oh-Oka K, Kojima Y, Uchida K, Yoda K, Ishimaru K, Nakajima S, Hemmi J, Kano H, Fujii-Kuriyama Y, Katoh R, Ito H, Nakao A. Induction of colonic regulatory T cells by mesalamine by activating the aryl hydrocarbon receptor. Cell Mol Gastroenterol Hepatol. 2017;4(1):135\u201351. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.03.010.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"9583_CR23","doi-asserted-by":"publisher","first-page":"e4561","DOI":"10.1371\/journal.pone.0004561","volume":"4","author":"JY Kim","year":"2009","unstructured":"Kim JY, Kajino-Sakamoto R, Omori E, Jobin C, Ninomiya-Tsuji J. Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis. PLoS ONE. 2009;4(2):e4561. https:\/\/doi.org\/10.1371\/journal.pone.0004561.","journal-title":"PLoS ONE"},{"key":"9583_CR24","doi-asserted-by":"crossref","unstructured":"David J Friedman\u00a01,\u00a0Beat M K\u00fcnzli,\u00a0Yousif I A-Rahim,\u00a0Jean Sevigny,\u00a0Pascal O Berberat,\u00a0Keiichi Enjyoji,\u00a0Eva Csizmadia,\u00a0Helmut Friess,\u00a0Simon C Robson. 2009 CD39 deletion exacerbates experimental murine colitis, and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Scie USA. 106 16788\u201393","DOI":"10.1073\/pnas.0902869106"},{"issue":"8","key":"9583_CR25","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben U, Loddenkemper Ch, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, K\u00fchl A. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7(8):4557\u201376.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"9583_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12026-021-09214-3","volume":"69","author":"G Fonseca-Camarillo","year":"2021","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Priego-Ranero \u00c1A, Z\u00fa\u00f1iga RB, Mart\u00ednez-Ben\u00edtez B, Yamamoto-Furusho JK. AKAP12\/Gravin is over-expressed in patients with ulcerative colitis. Immunol Res. 2021;69(5):429\u201335. https:\/\/doi.org\/10.1007\/s12026-021-09214-3.","journal-title":"Immunol Res"},{"issue":"3","key":"9583_CR27","doi-asserted-by":"publisher","first-page":"152095","DOI":"10.1016\/j.imbio.2021.152095","volume":"226","author":"G Fonseca-Camarillo","year":"2021","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Razo-L\u00f3pez N, Barreto-Z\u00fa\u00f1iga R, Mart\u00ednez-Ben\u00edtez B, Yamamoto-Furusho JK. Intestinal production of secreted protein acidic and rich in cysteine (SPARC) in patients with ulcerative colitis. Immunobiology. 2021;226(3):152095. https:\/\/doi.org\/10.1016\/j.imbio.2021.152095.","journal-title":"Immunobiology"},{"issue":"4","key":"9583_CR28","doi-asserted-by":"publisher","first-page":"e13004","DOI":"10.1111\/sji.13004","volume":"93","author":"G Fonseca-Camarillo","year":"2021","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Priego-Ranero \u00c1A, Mart\u00ednez-Ben\u00edtez B, Barreto-Z\u00fa\u00f1iga R, Yamamoto-Furusho JK. Expression of TOB\/BTG family members in patients with inflammatory bowel disease. Scand J Immunol. 2021;93(4):e13004. https:\/\/doi.org\/10.1111\/sji.13004.","journal-title":"Scand J Immunol"},{"key":"9583_CR29","doi-asserted-by":"publisher","first-page":"5140691","DOI":"10.1155\/2018\/5140691","volume":"2018","author":"G Fonseca-Camarillo","year":"2018","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Iturriaga-Goyon E, Yamamoto-Furusho JK. Differential expression of IL-36 family members and IL-38 by immune and nonimmune cells in patients with active inflammatory bowel disease. Biomed Res Int. 2018;2018:5140691. https:\/\/doi.org\/10.1155\/2018\/5140691.","journal-title":"Biomed Res Int"},{"key":"9583_CR30","doi-asserted-by":"publisher","unstructured":"Cole SP. Multidrug resistance protein 1 (MRP1, ABCC1), a \u201cmultitasking\u201d ATP-binding cassette (ABC) transporter. J Biol Chem. 2014 Nov 7;289(45):30880\u20138. https:\/\/doi.org\/10.1074\/jbc.R114.609248. Epub 2014 Oct 3. PMID: 25281745; PMCID: PMC4223294","DOI":"10.1074\/jbc.R114.609248"},{"key":"9583_CR31","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhou H, Yang S, Su D. Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer. Cell Biochem Funct. 2021 Mar;39(2):277\u2013286. https:\/\/doi.org\/10.1002\/cbf.3577. Epub 2020 Aug 20. PMID: 32815556; PMCID: PMC7983913).","DOI":"10.1002\/cbf.3577"},{"key":"9583_CR32","unstructured":"Ram\u00edrez-Cosmes A, Reyes-Jim\u00e9nez E, Zertuche-Mart\u00ednez C, Hern\u00e1ndez-Hern\u00e1ndez CA, Garc\u00eda-Rom\u00e1n R, Romero-D\u00edaz RI, Manuel-Mart\u00ednez AE, Elizarrar\u00e1s-Rivas J, V\u00e1squez-Garz\u00f3n VR. The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target? Am J Cancer Res. 2021 Sep 15;11(9):4127\u20134140"},{"key":"9583_CR33","doi-asserted-by":"publisher","unstructured":"Huang W, Chen K, Lu Y, Zhang D, Cheng Y, Li L, Huang W, He G, Liao H, Cai L, Tang Y, Zhao L, Pan M. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021 Dec;23(12):1227\u20131239. https:\/\/doi.org\/10.1016\/j.neo.2021.11.002. Epub 2021 Nov 9. PMID: 34768109; PMCID: PMC8591347.","DOI":"10.1016\/j.neo.2021.11.002"},{"key":"9583_CR34","doi-asserted-by":"publisher","unstructured":"(Shaughnessy CA, Zeitlin PL, Bratcher PE. Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment. Sci Rep. 2021 Oct 6;11(1):19810. https:\/\/doi.org\/10.1038\/s41598-021-99184-1. Erratum in: Sci Rep. 2021 Oct 25;11(1):21295. PMID: 34615919; PMCID: PMC8494914.).","DOI":"10.1038\/s41598-021-99184-1"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09583-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09583-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09583-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:30:02Z","timestamp":1770190202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09583-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9583"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09583-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the National Institute of Medical Sciences and Nutrition \u201cSalvador Zubir\u00e1n\u201d (GAS-2724\u201318-21\u20131). It was carried out following the principles of the Helsinki Declaration, and the written informed consent of all participants was obtained before enrollment. The animal study was reviewed and approved by all experimental procedures approved by the Institutional Animal Care and Use Committee (IACUC-GAS-1963\u201319-20\u20131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}